Researchers developed a deep learning framework for whole-body MRI-based body composition analysis, predicting mortality more accurately than traditional methods. This innovative approach could revolutionize personalized risk assessments and clinical workflows.
Meet this year’s Endpoints 11; J&J winds down cardiovascular and metabolic unit; BMS wins schizophrenia approval; and more
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS